Hi Eyeswideopen,
Join this dot: (mesoblast's announcement on December 17)
"The DSMB reported that there were no safety concerns and noted that the trial is not likely to meet the 30-day mortality reduction endpoint at the planned 300 patient enrolment"
In other words, its unlikely to meet its objective.
with this dot: (my previous post)
'The term 'futility' is used to refer to the inability of a clinical trial to achieve its objective'
Clearly the objective of the trial was to meet a 30-day mortality endpoint but the DSMB have indicated that the trial was unlikely to meet that objective.
Where's the ambiguity?
I also don't like the fact that the trial is being wound up due to 'futility' but it doesn't change the fact.
- Forums
- ASX - By Stock
- MSB
- COVID-19 USA Daily Numbers
COVID-19 USA Daily Numbers, page-354
-
- There are more pages in this discussion • 322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B |
Open | High | Low | Value | Volume |
$1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 31000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | 1.150 |
2 | 17000 | 1.140 |
1 | 40000 | 1.125 |
5 | 158332 | 1.100 |
2 | 15000 | 1.095 |
Price($) | Vol. | No. |
---|---|---|
1.155 | 31000 | 2 |
1.160 | 27391 | 2 |
1.170 | 22300 | 2 |
1.175 | 26294 | 3 |
1.180 | 85298 | 3 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |